Summary

Hip Replacement Market Size

Hip replacement market will grow, reaching nearly US$10.24 billion by 2033; by contrast, in 2024, it was US$6.92 billion. This increase is estimated to be a compound annual growth rate of 4.45% from 2025 to 2033. Some reasons for such an expansion are a growing older population, increasing cases of obesity, and enhanced surgical techniques through medical technology, which improves recovery times and outcomes for patients who undergo hip replacements.


Hip Replacement Market Insights

Hip replacement is a type of surgery wherein a diseased or damaged hip joint is removed and replaced with an artificial substitute, usually metal, ceramic, or plastic. This surgery is usually recommended to patients who suffer from severe pain, reduced mobility, or deteriorating joints brought about by diseases like arthritis, fractures, or any other conditions. The surgery is likely to have a great improvement in the quality of life through the relief of pain and joint functioning, which may enable patients to live their lives better.

Hip replacement has been a very popular procedure for many years because of improvements in surgical techniques and implant technology. Minimally invasive approaches and durable materials have reduced recovery times and improved outcomes. Moreover, an aging population and the prevalence of osteoarthritis have contributed to the rising demand for this procedure. Younger patients also opt for hip replacements as active lifestyles lead to joint wear and injuries. High success rate, better access to healthcare, and awareness increase its acceptance, making it a standard treatment option worldwide.


Growing Factors for Hip Replacement Market

Aging Population Worldwide

The major driver for increasing hip replacement demand is due to the aging population worldwide. With advancing age, the conditions like osteoarthritis and hip fracture enhance the trend for joint replacement surgery. The elderly is more likely to experience joint degeneration, causing pain and limited mobility. With an increasing number of elderly individuals seeking solutions to maintain independence and quality of life, the demand for hip replacements is expected to rise, particularly in developed countries with aging demographics. By 2030, 1 in 6 people will be 60 years or over. The share of population aged 60 years and over is going to be 1.4 billion in the year 2020 to 1.4 billion, which will increase double times, or 2.1 billion by 2050. The population aged 60 years and above in the world is going to increase threefold. The persons aged 80 years or more will be around 426 million by 2050.


Advancements in Implant Technology

Technological advancements in the implant materials and surgical techniques have dramatically improved the success rate of hip replacements. The modern implants are made from long-lasting materials like ceramics, titanium, and alloys, providing more durable results with less wear. Furthermore, minimal invasive techniques bring quicker recovery, smaller incisions, and less risk of complications. These innovations make hip replacement surgery more attractive to patients and healthcare providers, driving market growth by enhancing the quality of care and outcomes. Feb 2023, Maxon released several new motors at MD&M West, including a series suitable for surgical robots and implants and a line of frameless DT motors with internal rotor technology. The ECX SPEED 8 motors with pin connection also have a pin connection for a space-saving design.


Increasing Awareness and Accessibility

The awareness of the benefits of hip replacement surgery and the accessibility of health care have also driven the market forward. More patients are aware of the options for treatment for hip pain and mobility problems, thus leading to earlier intervention. Additionally, rising coverage of healthcare systems and insurance policies for joint replacement surgeries further reduce the procedure's cost. Specialized surgeons and better infrastructure for healthcare facilitate easy access for patients to the hip replacement surgery, thus supporting market growth. For example, as per the report from a study in the National Center of Biotechnology Information, a total of about 572,000 total hip arthroplasty cases will be reported by the year 2030. Additionally, as per the American Joint Replacement Registry study in 2022, between 2012 and 2021 in the U.S., there were about 2,550,530 hip and knee arthroplasty procedures, including both primary and revision surgeries, out of which around 37.3% were primary hip surgeries.


Challenges in the Hip Replacement Market

High Surgery Costs

Despite growing demand, one of the significant challenges in the hip replacement market is the high cost of the procedure, including hospital stays, surgical fees, and post-surgery rehabilitation. These costs can be prohibitive for patients without adequate insurance coverage, particularly in developing countries or regions with less accessible healthcare. High costs can limit the adoption of hip replacement surgery, especially among middle-income populations, creating barriers to access and slowing market growth in specific demographics.


Risk of Complications and Revisions

Hip replacement surgeries are typically very successful. However, it is not impossible to have associated risks with such a procedure as infections, blood clots, and implant failure. Some people may need their implants revised either because they break down, work loose, or cause complications to the patient at a later stage. This has implications on increasing healthcare costs, which may go on for a while. Challenges include complications, potential revision surgeries, and impact on the general perception of the procedure by both patients and providers.


Partial Hip Replacement Market

Partial hip replacement market is one that has recently experienced growth as well, in response to technological advancement in surgery techniques and rising awareness of this type of intervention. Unlike the total hip replacements, partial hip replacements are made to replace only the damaged portion of the hip. This ensures that the healing process is quicker and less damage is caused to the surrounding tissues. This type of replacement mainly benefits patients who have specific conditions such as fractures or early-stage arthritis. An expected increase in demand for partial hip replacements will augment the market during the aging of the population, as well as high obesity rates. In February 2024, the U.S. Food and Drug Administration approved the system for the use of robot-assisted surgery, including for hip replacement.


Hospitals & Surgery Centers Hip Replacement Market

The Hospitals & Surgery Centers Hip Replacement Market is growing at a rapid pace driven by the increase in incidence rates of hip conditions, especially within the geriatric population. New minimally invasive surgical techniques and advanced implant technologies are revolutionizing patient outcomes, and the demand for hip replacement procedures is growing at a very rapid pace. Hospitals and specialized surgery centers are responding to this increasing demand by improving their facilities and investing in the best professionals available. Additionally, educating patients on the benefits of early intervention and proper rehabilitation promotes proactive treatment choices. Sufficient insurance coverage and affordable pricing also enable patients to receive necessary care for their hip conditions without delay. On October 2024, Zimmer Biomet Holdings, Inc. announced the launch of the Z1™ Femoral Hip System for total hip arthroplasty. This triple-taper system is an addition to the G7® Acetabular System, providing surgeons with a versatile and efficient solution.


Canada Hip Replacement Market

The Canadian hip replacement market is largely experiencing growth due to a sedentary aging population and people experiencing conditions such as osteoarthritis. Improvement in surgical techniques and implant technologies also expands the market, shortens recovery times, and leads to more favorable patient outcomes. Public knowledge of treatments increases, and demand for hip surgeries rises. Improvement of access to the procedures has also been realized from government initiatives and healthcare investments. With the novel solutions and health care demands that are ever-rising, this market will go on developing within the following years, bringing prosperity to the patient and healthcare practitioners. In March 2022, Intellijoint Surgical is pleased to announce the first sale of its flagship product, Intellijoint HIP, to a public hospital in Canada.


Germany Hip Replacement Market

It has a strong hip replacement market driven by an increasingly aging population as well as increasing incidence of disorders related to hips. Advanced techniques in surgery combined with sophisticated materials for implants ensure better surgical results, thus giving satisfaction to patients. The health care standards and innovative medical technology in the country attract patients to Germany from across borders. The comprehensive rehabilitation programs carried out in this country also enhance recovery. German Government initiatives to increase health care access only fuels the growth of the market. Awareness of joint health in Germany can only fuel more hip replacement surgeries into the future. As on March 2024 Stryker releases the first surgeries using the GEuropean amma4 Hip Fracture Nailing System.


China Hip Replacement Market

The Chinese hip replacement market is growing at a rapid pace due to the increasing aging population, lifestyle-related diseases, and rising healthcare expenditures. As the economy of the country improves, more people can afford advanced medical treatments, thereby increasing the demand for hip replacement surgeries. Improved patient outcomes and recovery times are associated with innovations in implant technology and minimally invasive surgical techniques. Government initiatives for expanding access and quality of healthcare also support the markets' growth. Over the upcoming period, the Chinese market for hip replacements is expected to develop steadily with a view to improving the treatment alternatives and enhancing awareness of joint health. According to the recent government statistics published in January 2024, China's population aged 60 and older was about 297 million in 2023, making the country a "super-aged society" by the World Bank standards. That demographic is anticipated to rise to over half a billion by 2050. This population is susceptible to various bone-related conditions fueling market growth.


UAE Hip Replacement Market

The UAE hip replacement market is growing very fast due to the rising aged population and the increase in prevalence of orthopedic conditions. Technological advancements, such as minimally invasive surgery and new implant designs, have improved surgical outcomes and patient recovery. Improving health care services, supported by substantial government investments, makes the UAE's access to more advanced treatments possible. Moreover, enhanced awareness of hip joint health throughout the population escalates the volume of hip replacement surgeries. Based on the strategic development of these service providers through the improvement in patient care service, the coming years are seen to be in ascending order. Gargash Hospital, the UAE's first female Emirati-owned, multi-specialty hospital, is partnering with KEF Holdings' Meitra Hospital to create a Center of Excellence for Bone and Joint in the UAE, which will become operational in Mar 2022.


Product – Market breakup from 3 viewpoints:
1. Total HIP Replacement
2. Partial HIP Replacement
3. Revision HIP Replacement


End-User – Market breakup from 3 viewpoints:
1. Hospitals & Surgery Centers
2. Orthopaedic clinics
3. Others


Country – Market breakup from
1. North America

1.1 United States
1.2 Canada

2. Europe

2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey

3. Asia Pacific

3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand

4. Latin America

4.1 Brazil
4.2 Mexico
4.3 Argentina

5. Middle East and Africa

5.1 Saudi Arabia
5.2 UAE
5.3 South Africa

6. Rest of World


All key players have been covered from 3 viewpoints:
1. Overview
2. Recent Development
3. Sales Analysis


Company Analysis:
1. Smith & Nephew PLC
2. Johnson & Johnson
3. Integra lifesciences Corporation
4. Zimmer Biomet
5. Stryker
6. B. Braun Melsungen AG
7. Globus Medical Inc
8. MicroPort Scientific Corporation
9. Conformis Inc

ページTOPに戻る

Table of Contents

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges


5. Global Hip Replacement Market


6. Market Share
6.1 By Products
6.2 By End User
6.3 By Countries


7. Products
7.1 Total
7.2 Partial
7.3 Revision & Hip Resurfacing


8. End User
8.1 Hospitals & Surgery Centers
8.2 Orthopedic Clinics
8.3 Others


9. Countries
9.1 North America

9.1.1 United States
9.1.2 Canada

9.2 Europe

9.2.1 France
9.2.2 Germany
9.2.3 Italy
9.2.4 Spain
9.2.5 United Kingdom
9.2.6 Belgium
9.2.7 Netherlands
9.2.8 Turkey

9.3 Asia Pacific

9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Thailand
9.3.6 Malaysia
9.3.7 Indonesia
9.3.8 Australia
9.3.9 New Zealand

9.4 Latin America

9.4.1 Brazil
9.4.2 Mexico
9.4.3 Argentina

9.5 Middle East and Africa

9.5.1 Saudi Arabia
9.5.2 UAE
9.5.3 South Africa

9.6 Rest of World


10. Porter’s Five Forces
10.1 Bargaining Power of Buyer
10.2 Bargaining Power of Supplier
10.3 Threat of New Entrants
10.4 Rivalry among Existing Competitors
10.5 Threat of Substitute Products


11. SWOT Analysis
11.1 Strengths
11.2 Weaknesses
11.3 Opportunities
11.4 Threats


12. Key Players Analysis
12.1 Smith & Nephew PLC

12.1.1 Business Overview
12.1.2 Recent Development
12.1.3 Sales Analysis

12.2 Johnson & Johnson

12.2.1 Business Overview
12.2.2 Recent Development
12.2.3 Sales Analysis

12.3 Integra lifesciences Corporation

12.3.1 Business Overview
12.3.2 Recent Development
12.3.3 Sales Analysis

12.4 MicroPort Scientific Corporation

12.4.1 Business Overview
12.4.2 Recent Development
12.4.3 Sales Analysis

12.5 Zimmer Biomet

12.5.1 Business Overview
12.5.2 Recent Development
12.5.3 Sales Analysis

12.6 Stryker

12.6.1 Business Overview
12.6.2 Recent Development
12.6.3 Sales Analysis

12.7 B. Braun Melsungen AG

12.7.1 Business Overview
12.7.2 Recent Development
12.7.3 Sales Analysis

12.8 Globus Medical Inc

12.8.1 Business Overview
12.8.2 Recent Development
12.8.3 Sales Analysis